Not Yet RecruitingNot Applicable

HBM-Based Education for Retinopathy of Prematurity Screening in Parents of Premature Infants

99 participantsStarted 2026-07

Plain-language summary

The goal of this clinical trial is to learn whether Health Belief Model (HBM)-based educational interventions can improve knowledge and practices related to Retinopathy of Prematurity (ROP) screening among parents of premature infants attending ROP clinics in Karachi, Pakistan. The main questions it aims to answer are: * Do HBM-based educational interventions improve parents' knowledge about Retinopathy of Prematurity screening? * Do HBM-based educational interventions improve parents' screening-related practices and follow-up for Retinopathy of Prematurity? Researchers will compare different educational approaches, including video-based education, audio-based education, and standard educational material, to see which method is more effective in improving parental understanding and practices regarding ROP screening. Participants will: * Complete a questionnaire assessing their knowledge and practices related to Retinopathy of Prematurity screening at baseline * Receive one of the following educational approaches: video message plus counselling and pamphlet, audio message plus counselling and pamphlet, or counselling and pamphlet only * Attend a follow-up visit approximately 2 weeks after the initial visit * Complete a follow-up questionnaire to assess changes in knowledge and practices related to Retinopathy of Prematurity screening

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Mother or father of a premature infant attending Retinopathy of Prematurity (ROP) clinic * Parent aged 18 years or older * Parent of a premature infant who was admitted to the Neonatal Intensive Care Unit (NICU) * Able to understand English or Urdu * Willing and able to provide written informed consent Exclusion Criteria: * Parents with disability or cognitive impairment affecting participation * Uncooperative participants * Parents unwilling or unable to provide informed consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Retinopathy of Prematurity Knowledge Score

Timeframe: Baseline to follow-up visit (approximately 2 weeks after initial visit)

Trial details

NCT IDNCT07661654

SponsorAga Khan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-02

Contact for this trial

Khadijah Abid

+92-021-34930051 khadijah.abid@aku.edu

View on ClinicalTrials.gov More Retinopathy of Prematurity (ROP) trials